Atom Investors LP

Position in COGT — Cogent Biosciences, Inc.

CIK 1738902 AUSTIN, TX

Position in COGT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$2,526,374

-$848,275 QoQ

Shares Held

65,281

-25.5% QoQ

Ownership

0.038%

of shares outstanding

% of Portfolio

0.24%

of 13F equity value

Holder Rank

#154

of 321 holders

Holding Since

Dec 2021

15 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

Atom Investors LP holds $106,011,536 across 52 Biotechnology names. COGT ranks #20 (2.4% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	RYTM	Rhythm Pharmaceuticals, Inc.	73,465	$8,156,818
2	IMNM	Immunome Inc.	297,489	$6,303,791
3	RARE	Ultragenyx Pharmaceutical Inc.	171,771	$5,735,433
4	DNTH	Dianthus Therapeutics, Inc. /DE/	37,228	$3,628,985
5	CELC	Celcuity Inc.	34,488	$3,608,134
6	SNDX	Syndax Pharmaceuticals Inc	162,524	$3,552,774
7	AXSM	Axsome Therapeutics, Inc.	14,179	$3,470,593
8	JAZZ	Jazz Pharmaceuticals plc	13,474	$3,246,829

15 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,526,374	65,281	-25.5%	Shares	Sole	2026-08-14
2026-03-31	$3,374,649	87,676	+384.2%	Shares	Sole	2026-05-15
2025-12-31	$643,196	18,108	+26.8%	Shares	Sole	2026-02-17
2024-12-31	$111,360	14,277	-38.4%	Shares	Sole	2025-02-14
2024-06-30	$195,356	23,174	-42.8%	Shares	Sole	2024-08-14
2024-03-31	$272,039	40,482	-60.8%	Shares	Sole	2024-05-15
2023-12-31	$606,910	103,216	+176.0%	Shares	Sole	2024-02-14
2023-09-30	$364,630	37,398	+181.3%	Shares	Sole	2023-11-14
2023-06-30	$157,400	13,294	-43.3%	Shares	Sole	2023-08-14
2023-03-31	$252,982	23,446	-72.2%	Shares	Sole	2023-05-15
2022-12-31	$975,016	84,344	+128.2%	Shares	Sole	2023-02-14
2022-09-30	$551,473	36,962	-53.7%	Shares	Sole	2022-11-08
2022-06-30	$719,444	79,761	-30.9%	Shares	Sole	2022-08-15
2022-03-31	$864,555	115,428	+88.1%	Shares	Sole	2022-05-16
2021-12-31	$526,468	61,360	—	Shares	Sole	2022-02-14
No filing history on record for this holder in this stock.